CVS Group plc (LON:CVSG)
London · Delayed Price · Currency is GBP · Price in GBX 1,233.00
+12.00 (0.98%)
Sep 25, 2026, 2:38 PM GMT
CVS Group Market Cap
CVS Group has a market cap or net worth of 835.68 million as of September 25, 2026. Its market cap has decreased by -6.21% in one year.
Market Cap
835.68M
Enterprise Value
1.14B
Revenue
712.80M
Ranking
n/a
PE Ratio
50.25
Stock Price
1,233.00
ChartMarket Cap Chart
Since October 10, 2007, CVS Group's market cap has increased from 4.71M to 835.68M, an increase of 17,631.84%. That is a compound annual growth rate of 31.38%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2026 | 835.68M | -7.96% |
| Dec 31, 2025 | 907.93M | 50.66% |
| Dec 31, 2024 | 602.62M | -49.95% |
| Dec 29, 2023 | 1.20B | -12.67% |
| Dec 30, 2022 | 1.38B | -13.16% |
| Dec 31, 2021 | 1.59B | 49.49% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 192.79B |
| GSK plc | 75.57B |
| Haleon | 30.38B |
| Smith & Nephew | 8.47B |
| HUTCHMED (China) | 1.89B |
| Oxford Nanopore Technologies | 1.71B |
| Genus | 1.41B |
| Spire Healthcare Group | 983.47M |